Editorial: Benefit of Direct-Acting Antiviral Therapy for Cryoglobulinemia due to Hepatitis C Infection

Paul Martin, Fabizio Fabrizi

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Extrahepatic consequences of hepatitis C infection are increasingly recognized as a source of additional morbidity distinct from the consequences of liver disease. Among the best characterized of these is mixed cryoglobulinemia, which can lead to a variety of disorders, including vasculitis and glomerulonephritis. In general, the results of antiviral therapy in the interferon era had been disappointing, but now with new all-oral regimens response rates are substantially better. However, even with successful clearance of the virus symptomatic response can lag.

Original languageEnglish (US)
Pages (from-to)1309-1310
Number of pages2
JournalAmerican Journal of Gastroenterology
Volume112
Issue number8
DOIs
StatePublished - Aug 1 2017

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Editorial: Benefit of Direct-Acting Antiviral Therapy for Cryoglobulinemia due to Hepatitis C Infection'. Together they form a unique fingerprint.

  • Cite this